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The scavenger receptor cysteine-rich (SRCR) family comprises a group of membrane- 
attached or secreted proteins that contain one or more modules/domains structurally 
similar to the membrane distal domain of type I macrophage scavenger receptor. Although 
no all-inclusive biological function has been ascribed to the SRCR family, some of these 
receptors have been shown to recognize pathogen-associated molecular patterns (PAMP) 
of bacteria, fungi, or other microbes. SSc5D is a recently described soluble SRCR receptor 
produced by monocytes/macrophages and T lymphocytes, consisting of an N-terminal 
portion, which contains five SRCR modules, and a large C-terminal mucin-like domain. 
Toward establishing a global common role for SRCR domains, we interrogated whether 
the set of five SRCR domains of SSc5D displayed pattern recognition receptor (PRR) 
properties. For that purpose, we have expressed in a mammalian expression system the 
N-terminal SRCR-containing moiety of SSc5D (N-SSc5D), thus excluding the mucin-like 
domain likely by nature to bind microorganisms, and tested the capacity of the SRCR 
functional groups to physically interact with bacteria. Using conventional protein–bacteria 
binding assays, we showed that N-SSc5D had a superior capacity to bind to Escherichia 
coli strains RS218 and IHE3034 compared with that of the extracellular domains of the 
SRCR proteins CD5 and CD6 (sCD5 and sCD6, respectively), and similar E. coli-binding 
properties as Spα, a proven PRR of the SRCR family. We have further designed a more 
sensitive, real-time, and label-free surface plasmon resonance (SPR)-based assay and 
examined the capacity of N-SSc5D, Spα, sCD5, and sCD6 to bind to different bacteria. 
We demonstrated that N-SSc5D compares with Spα in the capacity to bind to E. coli and 
Listeria monocytogenes, and further that it can distinguish between pathogenic E. coli 
RS218 and IHE3034 strains and the non-pathogenic laboratory E. coli strain BL21(DE3). 
Our work thus advocates the utility of SPR-based assays as sensitive tools for the 
rapid screening of interactions between immune-related receptors and PAMP-bearing 
microbes. The analysis of our results suggests that SRCR domains of different members 
of the family have a differential capacity to interact with bacteria, and further that the same 
receptor can discriminate between different bacteria strains and species.
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inTrODUcTiOn
Pattern recognition receptors (PRR) are membrane-bound 
or cytosolic receptors of plants and animals that are capable 
of interacting with pathogen-associated molecular patterns 
(PAMP), including lipopolysaccharide (LPS) of Gram-negative 
bacteria, the Gram-positive bacteria lipotheicoic acid (LTA) 
and peptydoglycan (PGN), as well as the fungi polysaccharides 
Zymosan or β-glucan, thus providing a first line of immune 
defense against microbes or their secreted toxins. Several 
families of PRR have been reported to be specific for patho-
gens or virulence factors, and they include Toll-like receptors, 
nucleotide-binding oligomerization domain (NOD)-like recep-
tors, retinoic acid-inducible gene I (RIG-I)-like receptors, and 
C-type lectin receptors, among others (1). In contrast, recep-
tors belonging to yet another group, the scavenger receptor 
cysteine-rich superfamily (SRCR-SF), are seldom referred to as 
pathogen-recognition molecules, despite the fact that several 
SRCR receptors have been shown to bind to and clear bacteria, 
fungi, or viruses from infected hosts (2).
Scavenger receptor cysteine-rich members are present in all 
animal phyla and although individual proteins may have vari-
ous roles in, for example, cell differentiation, iron metabolism, 
homeostasis, or apoptosis, most SRCR proteins are thought to 
serve immune-related functions (3). A subfamily (group B) of the 
SRCR-SF consists of members present only in vertebrates (4), and 
four of the nine receptors described in humans have been shown 
to bind to bacteria or bacterial components. CD6 and CD163 are 
membrane-bound receptors of T cells and macrophages, respec-
tively; DMBT1, which has a broad expression profile, and Spα, a 
soluble glycoprotein expressed by macrophages in the lymphoid 
tissues and highly present in the serum [detection levels of micro-
gram per milliliter (5)], are molecular sensors of Gram-positive 
and Gram-negative bacteria (6–9). Although shown not to bind 
to either Gram-positive or -negative bacteria, the T cell surface 
SRCR protein CD5 is reported to interact with conserved fungal 
components and to aggregate fungal cells (10).
After bacterial challenges, the soluble SRCR protein Spα 
is immediately released from human macrophages to control 
bacteria spreading and inflammatory cytokine secretion by 
PRR-expressing innate cells (9). In vivo studies of PAMP-induced 
septic shock have shown that the levels of the Spα mouse homolog 
(mAIM/Api6/Cd5L) increase rapidly upon injection of LPS or 
Zymosan, further suggesting that this SRCR protein can act as a 
circulating PRR (11). SSc5D is a recently described soluble SRCR 
protein that shares many features with Spα. SSc5D is expressed in 
macrophages, T cells, and several epithelial cells, especially from 
placenta, spleen, and colon (12). It is also highly abundant in the 
serum and shows increased levels in inflammatory conditions 
(13). The mouse homolog of SSc5D [S5D-SRCRB (14)] is also 
upregulated upon infection and seems capable to bind bacteria 
(15), although this has not been reported for the human coun-
terpart. A major difference between SSc5D and Spα relates not 
only to the number of SRCR domains (5 and 3, respectively) but 
also to the existence of a large mucin-like sequence located at the 
C-terminus of SSc5D. In the human molecule, this domain rep-
resents about 40% of the amino acid content of the whole protein, 
and it is expected that, similar to other O-glycosylated mucin-like 
proteins, it may bind and modulate pathogen behavior.
Label-free biosensors have revolutionized the qualitative 
and quantitative analysis of biomolecular interactions (e.g., 
protein–protein or protein–nucleic acids interactions) and are 
also broadly used in medical diagnostics, environmental moni-
toring, or food safety and security (16). Highly sensitive detec-
tion technology, such as surface plasmon resonance (SPR) that 
allows real-time studies of molecular binding processes, has been 
recently applied to the detection of bacteria and other microbial 
pathogens (17–19). These early studies have relied on the use 
of high-affinity antibodies recognizing particular components 
of bacterial surfaces. Despite the considerably weaker binding 
affinities for common receptor–ligand pairs when compared 
with antibody–antigen interactions, we hypothesized that an 
analogous strategy could be set up to scrutinize the interaction of 
secreted SRCR proteins with whole cell bacteria if these interac-
tions were strong enough, reflecting a potential PRR nature of 
SRCR proteins.
In this work, we demonstrate the ability of SPR biosensor 
technology to monitor the interaction of secreted SRCR proteins 
with whole cell bacteria of different types. We have assessed the 
bacteria-binding capacity of the N-terminal moiety of SSc5D 
(excluding the mucin-like sequence likely to bind bacteria per se) 
and compared with the equivalent domains of other SRCR-family 
proteins, soluble Spα, and the extracellular domains of CD5 
and CD6. The SPR experiments demonstrate the differential 
bacteria-binding capacity of N-SSc5D compared with the other 
SRCR proteins, and that globally these receptors can qualitatively 
distinguish between different types of bacteria.
MaTerials anD MeThODs
recombinant Protein Production and 
Purification
The soluble extracellular domain of CD6 (sCD6) was produced 
as previously described (20), and the remaining recombinant 
 proteins (N-SSc5D, Spα, and sCD5) were expressed and puri-
fied  as   follows. A cDNA corresponding to the N-terminal half 
of SSc5D (exons 1–12), which includes the five SRCR domains 
(N-SSc5D) (12), was amplified by PCR from human placenta 
cDNA using  forward 5′-TATAATGGATCCGAGCGCCTGCG 
CCTGGCCGAT and reverse 5′-AATAGGATCCCTCTTGTGTC 
CGGCAGGCGCCTTATTGCTGG primers (BamHI restriction 
sites are underlined). The Spα cDNA was amplified by PCR from 
human spleen cDNA using forward 5′-TTAGGATCCTCTCC 
ATCTGGTGTGCGGCTG and reverse 5′-CAAGGATCCACC 
TGAGCAGATGACAGCCAC primers. A cDNA fragment 
encoding the extracellular domain of human CD5 (residues 
Arg25-Ser348; sCD5) was amplified by PCR from a template CD5-
pGFP-N1 kindly provided by G. Bismuth (Institut Cochin, Paris) 
using forward 5′-TAGGGATCCCGGCTCAGCTGGTATGAC 
and reverse 5′-CTAGGATCCCGGGGTTTGGATCTTGGCAT 
primers. Each cDNA was inserted into the BamHI sites of the 
lab-modified version of pEE14 in order to obtain chimeric 
cDNAs encoding, in the following order, signal peptide, HA-tag, 
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the specific protein sequence (Spα, N-SSc5D, or sCD5), a BirA 
recognition sequence, and 6⋅His tag sequences.
The sCD5, N-SSc5D, and Spα vectors were transfected into 
CHO-K1 cells using Lipofectamine (Invitrogen). Clones resist-
ant to 30-μM methionine sulfoximine (MSX) were selected (21) 
and screened for soluble CD5 (HA-sCD5-BirA-His), N-SSc5D 
(HA-N-SSc5D-BirA-His), and Spα (HA-Spα-BirA-His) expres-
sion using dot blots and western blots. The best clones expressing 
HA-sCD5-BirA-His, HA-N-SSc5D-BirA-His, and HA-Spα-BirA-
His were selected for large-scale production of protein and grown 
in cell factories (Nunc). Proteins secreted into tissue culture 
supernatants were harvested after approximately 4  weeks and 
purified by metal-chelate chromatography using Ni Sepharose 
High Performance (HisTrap HP, GE Life Sciences). HA-sCD5-
BirA-His was eluted from the Ni column with 250 mM imidazole 
in PBS, while HA-N-SSc5D-BirA-His and HA-Spα-BirA-His 
were eluted with 40 mM imidazole in PBS. Fractions containing 
the HA-N-SSc5D-BirA-His and HA-Spα-BirA-His were further 
purified by anionic chromatography (UNO Q column BioRad) 
with 1  M NaCl. The previously produced recombinant protein 
sCD6 also conformed to a similar structure as the newly produced 
proteins, having a HA-sCD6-BirA-His sequence.
Protein purity was analyzed by SDS-PAGE (Figure S1 in 
Supplementary Material). Samples of the fractions obtained by 
chromatography were run for 1  h at 150  V, and the gels were 
stained with Bio-Safe Coomassie Premixed Staining Solution 
(Bio-Rad Laboratories) for visualization of the protein products.
For N-SSc5D immunoblotting, samples were run in SDS-
PAGE for 1 h at 150 V with Tris/glycine/SDS running buffer (Bio-
Rad Laboratories). Samples were transferred to the nitrocellulose 
membrane using the iBlot™ Gel Transfer Device (Invitrogen) 
following the manufacturer’s instructions. Then, the membrane 
was blocked with TBS, 0.1% Tween 20 (TBS-T), containing 5% 
non-fat dried milk, for 1  h with shaking. N-SSc5D was subse-
quently detected with rabbit anti-SSc5D (Abgent, 1:5,000) pri-
mary antibody in TBS-T with 3% non-fat dried milk, for 1 h at RT, 
followed by peroxidase-conjugated goat anti-rabbit IgG antibody 
(Sigma, 1:30,000) for 1 h at RT. The immunoblot was developed 
using ECL detection reagent (GE Healthcare Life Sciences), and 
the image was acquired in a ChemiDoc XRS+ system (Bio-Rad 
Laboratories).
Bacteria strains
Listeria monocytogenes EGD-e was grown in brain heart infusion 
(BHI) medium (BD-Difco) at 37°C to an optical density of 0.6 at 
600 nm (OD600; exponential phase), and Escherichia coli strains 
[BL21(DE3), IHE3034, RS218] were grown in LB medium at 
37°C to an OD600 of 0.45.
conventional Bacteria–Protein  
Binding assays
Recombinant proteins Spα, N-SSc5D, sCD6, and sCD5 (5 μg per 
assay) were incubated for 1 h at 4°C with the indicated cell suspen-
sions of live bacteria (1 × 108 cells) in binding buffer (TBS, 1% BSA, 
5 mM CaCl2). Suspensions were centrifuged at 4,000 × g for 5 min 
at 4°C. Cell pellets were washed thoroughly, then resuspended 
in 40-μl Laemmli’s sample buffer, and denatured by heating at 
95°C for 10 min. Next, 20 μl of this lysate and pure recombinant 
proteins (25 or 100 ng) were separated in 6% SDS-PAGE. The gel 
was run for 1 h at 150 V with Tris/glycine/SDS running buffer 
(Bio-Rad Laboratories). After the SDS-PAGE, proteins were 
transferred to the nitrocellulose membrane using the iBlot™ 
Gel Transfer Device (Invitrogen) following the manufacturer’s 
instructions. Then, the membrane was blocked with TBS-T con-
taining 5% non-fat dried milk, for 1 h. Cell-bound protein was 
subsequently detected using mouse IgG1 anti-HA (clone 16B12) 
from Covance (0.1 μg/ml) in TBS-T with 3% non-fat dried milk, 
for 1  h at RT, followed by goat anti-mouse HRP-conjugated 
(Santa Cruz Biotechnology) (0.02 μg/ml) in the same conditions. 
The immunoblot was developed using ECL detection reagent 
(GE Healthcare Life Sciences), and the image was acquired in a 
ChemiDoc XRS+ system (Bio-Rad Laboratories).
sPr-Based Detection of Whole Bacterial 
cell interaction with srcr Proteins
We used a laboratory four-channel SPR platform based on the 
wavelength spectroscopy of surface plasmons (Plasmon IV) (22) 
developed at the Institute of Photonics and Electronics, Czech 
Republic. In this SPR biosensor, the sensor response is expressed 
as a shift in the wavelength of SPR resonance and is directly 
proportional to the mass of biomolecules attached to the surface 
of the sensor. Using the calibration procedure described in Ref. 
(23), the surface density of both the immobilized receptors and 
the subsequently attached molecules can be determined. For an 
SPR resonance of around 750 nm, the shift of 1 nm in the SPR 
wavelength represents a change in the protein surface coverage 
of 17 ng/cm2 (23). All the experiments were performed at 25°C. 
Buffers used were SA10 (10  mM sodium acetate, pH 4.0/5.0), 
PBS (10 mM phosphate, 2.9 mM KCl, 137 mM NaCl, pH 7.4), 
PBNa (10 mM phosphate, 2.9 mM KCl, 750 mM NaCl, pH 7.4), 
and Tris (10 mM Tris-HCl, pH 7.4).
Functionalization of the sensor chip
The sensor chip was functionalized with a mixed self-assembled 
monolayer (SAM) by incubating the cleaned gold chip in 
degassed absolute ethanol with a mixture (7:3) of HSC11(EG)4OH 
and HSC11(EG)6OCH2COOH alkanethiols at a final concentra-
tion of 200  μM. The HSC11(EG)6OCH2COOH alkanethiols 
terminated with a carboxylic head group were used to anchor a 
receptor by amino coupling, while HSC11(EG)4OH alkanethiols 
terminated with hydroxylic group were used to form a stable 
non-fouling background. For that purpose, the sensor chip was 
immersed in a mixed thiol solution at a temperature of 40°C for 
10 min and then stored overnight in the dark at RT. After the 
formation of the mixed SAM, the chip was removed from the 
solution, rinsed with absolute ethanol and deionized water, and 
dried with nitrogen. The chip was then immediately mounted 
to the prism on the SPR sensor. The activation of carboxylic 
terminal groups was performed in  situ by injecting deionized 
water followed by a 1:1 mixture of NHS and EDC for 5 min and 
deionized water again.
Conditions for immobilization have been optimized in terms 
of running buffer composition and pH, as well as sufficient surface 
coverage. Immobilization of proteins via covalent attachment to 
FigUre 1 | spα and n-ssc5D bind bacteria. Recombinant Spα, 
N-SSc5D, sCD6, and sCD5 were incubated (5 μg each sample) with 
suspensions of 1 × 108 CFU of live E. coli, strains BL21(DE3), IHE3034, or 
RS218, or with L. monocytogenes, strain EGD-e. Cell-bound proteins were 
detected by immunoblotting using anti-HA mAb. Pure recombinant proteins 
were also run (100 and 25 ng, left lanes) to determine the sensitivity of the 
assay.
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COOH/OH SAM was performed at a flow rate of 30 μl/min and a 
temperature of 25°C. To immobilize the receptors, sodium acetate 
(SA10) pH 4.0 (Spα, N-SSc5D, and sCD6) or 5.0 (sCD5) was 
flowed trough the activated surface until a baseline was achieved. 
Then, the SA10 solutions containing the receptors (2–5 μg/ml) 
were flowed across the activated surface until a desired surface 
coverage was achieved. To remove the non-covalently bound 
receptors, the high ionic strength PBNa buffer was flowed along 
the sensor surface. Finally, the sensor surface was treated with 
1 M EA to deactivate residual carboxylic groups.
Detection of the interaction  
of srcrs with Bacteria
Bacteria cells were pelleted by centrifugation (4,000 × g, 5 min) 
and resuspended in PBS. Then, to preserve bacterial cell morphol-
ogy and to increase the sensitivity of the detection, cell aliquots 
were exposed to isopropanol (final concentration, 70% v/v) for 
20 min at RT. The pellets of isopropanol-fixed cells were obtained 
by centrifugation at 7,000 × g for 5 min and washed twice with 
PBS. Next, running buffer was flowed along the sensor surface 
until the baseline was achieved. Bacteria were resuspended in 
the running buffer at a concentration of 1 × 107 CFU/ml (or as 
indicated in the text) and delivered at a flow rate of 50 μl/min 
to the sensor surfaces with the immobilized proteins. Then, the 
running buffer was introduced again. The binding of bacteria to 
the sensor surface was detected as the difference in the sensor 
response between the equilibrium level after washing the bound 
surface with the running buffer and the baseline level obtained 
before the injection of the bacteria solution.
In this work, we used reference-compensated measurements 
and tested several different surfaces to be used as a reference sur-
face. These included a surface without receptors, surfaces covered 
with blocking molecules such as BSA, casein, or NeutrAvidin, and 
a surface with immobilized reference protein (sCD5). The study 
revealed that there was considerable adsorption of bacteria to a 
bare alkylthiolate SAM (used as a functional layer) without any 
receptors/molecules immobilized and that the binding of bacteria 
to the surface coated with blocking molecules was significantly 
higher than that observed in case of surface coated with a refer-
ence protein. Therefore, this approach was selected as the best 
option.
resUlTs
Detection of n-ssc5D Binding to Bacteria 
in conventional Bacteria–Protein  
Binding assays
We first assessed the binding of the SRCR-containing extracel-
lular domains of Spα, SSc5D, CD6, and CD5 (respectively, 
Spα, N-SSc5D, sCD6, and sCD5) to E. coli strains BL21(DE3), 
IHE3034, and RS218, and to L. monocytogenes strain EGD-e, 
using conventional bacteria-protein binding assays. Although 
Spα, sCD5, and sCD6 had previously been tested for bacteria 
binding (6, 9, 10), no experiments had been performed for SSc5D. 
We incubated 5 μg of each recombinant SRCR protein with bacte-
rial suspensions of 1 × 108 live cells (colony-forming units, CFU) 
at 4°C, followed by centrifugation and immunoblotting of the 
pelleted bacteria.
We confirmed the interaction of recombinant Spα with all bac-
terial samples tested, having an enhanced capacity to bind E. coli 
RS218 comparing with the other bacteria strains (Figure  1). 
However, and in contrast with previous studies, no detectable 
sCD6 was recovered in association with the bacterial pellets, using 
our experimental setup. There was also no bacteria-bound sCD5 
detected, but this was expected, given that CD5 was reported 
not to bind to bacteria (10). As observed from the experiments, 
N-SSc5D distinctly detected E. coli RS218 and IHE3034, although 
there was no conclusive evidence at this stage that it could bind to 
E. coli BL21(DE3) or to L. monocytogenes.
n-ssc5D and spα Binding to Bacteria  
is Measurable by sPr
The results from the previous experiment suggested that different 
SRCR proteins had distinct binding properties to different bacte-
rial strains, which might not have been highlighted in previous 
publications, each addressing a different SRCR protein at a time. 
Aware that western blot detection might not be the most sensitive 
method to emphasize these differences, we designed a new SPR-
based assay to enhance the sensitivity of detection of extracellular 
proteins binding to bacteria. In this assay, the proteins are directly 
attached to the sensor chip by amine coupling. Suspensions of 
isopropanol-fixed bacteria, resuspended at a concentration of 
1 × 107 CFU/ml or lower, are then delivered to the sensor surface 
containing the immobilized proteins. The output of the SPR sen-
sor (expressed in nanometer of resonant wavelength) is directly 
proportional to the amount of biomolecules attached to the active 
surface of the sensor. The difference in the sensor output before 
FigUre 2 | sPr detection of n-ssc5D binding to E. coli rs218 and L. monocytogenes egD-e. Recombinant Spα (a) or N-SSc5D (B), as well as the 
control sCD5 were immobilized in sensorchips and flowed with E. coli RS218 (left) or L. monocytogenes EGD-e (right) suspensions of 1 × 107 CFU/ml. After injection 
stopped, bacteria were retained in the different surfaces containing the SRCR proteins according to the strength of binding. Data are representative of multiple 
experiments with similar results. R.U., response units.
5
Bessa Pereira et al. SPR Detection of SSc5D–Bacteria Interactions
Frontiers in Immunology | www.frontiersin.org October 2016 | Volume 7 | Article 416
injection of bacteria (baseline level) and after washing the surface 
with captured bacteria in buffer is therefore proportional to the 
amount of bacteria captured (irreversibly bound) by the proteins 
immobilized on the sensor surface. This quantity was used to 
characterize the ability of the respective immobilized proteins to 
bind bacteria.
We considered the following as references for the binding 
spectra: (a) the positive interaction of Spα with neuropathogenic 
E. coli K1 RS218 and with L. monocytogenes EGD-e and (b) the 
null interaction of sCD5 with both bacteria species (Figure 2A). 
Spα and sCD5 were immobilized in alternate flow chambers, bac-
teria were injected at 1 × 107 CFU/ml, and SPR plots registered.
Next, we tested whether the interactions of N-SSc5D with 
E.  coli RS218 and L. monocytogenes EGD-e were measurable 
by SPR. As illustrated in Figure  2B, the interaction levels of 
N-SSc5D  with bacteria were lower than those of Spα in both 
cases (between 15 and 40% across several experiments), but 
quite distinct from the profiles obtained for sCD5. These results 
confirmed the WB detection of the N-SSc5D-E. coli RS218 inter-
actions seen in Figure 1, but further advanced in the detection 
of a subtle interaction between N-SSc5D with L. monocytogenes.
The results were reliable and qualitatively consistent among 
experiments, with only small variations in the absolute values of 
the responses. The chip-to-chip reproducibility of the interaction 
was >82% and >95% for N-SSc5D and sCD5 binding, respec-
tively. The reproducibility values were determined from three 
independent experiments for each protein.
n-ssc5D can Distinguish between 
Bacterial strains
To test whether N-SSc5D could have a different capacity to bind 
different E. coli strains, we immobilized N-SSc5D and simultane-
ously injected, in separate flow channels, the non-pathogenic 
laboratory BL21(DE3) strain, and the meningitis-causing RS218 
and IHE3034 E. coli strains. As another control of null-binding, 
we used in the fourth flow channel, heat-killed IHE3034. In 
parallel, we performed the same experiment with immobilized 
Spα. As seen in Figure  3, E. coli RS218 gave the best binding 
curve to N-SSc5D, followed by IHE3034, and finally BL21(DE3). 
Heat-killed IHE3034 only marginally bound to N-SSc5D, sug-
gesting that the bacterial determinants recognized by N-SSc5D 
are destroyed by heat. The binding profile of Spα to the different 
E. coli strains was not too different, binding marginally better to 
RS218 and BL21(DE3) than N-SSc5D, and less to IHE3034 than 
N-SSc5D, indicating that these proteins have slightly distinct 
FigUre 3 | Temporal sensor response to the differential binding of n-ssc5D and spα to different E. coli strains. Recombinant N-SSc5D (and Spα in 
parallel experiments) was immobilized in the four sensing channels and simultaneously injected suspensions of 1 × 107 CFU/ml of E. coli RS218, IHE3034, or E. coli 
BL21(DE3). The fourth flow channel was used to flow heat-killed IHE3034. After 10 min of injection, bacteria were differently retained in the four different sensor 
chambers. Data are representative of multiple experiments with similar results.
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recognition profiles but can nevertheless distinguish between 
different bacterial strains.
Differential Binding of srcr Proteins to 
a same Bacterial strain
To directly assess the differential binding capacity of the different 
SRCR receptors to a same bacterial preparation, we immobilized 
Spα, N-SSc5D, sCD6, and sCD5 in the four sensing channels 
and simultaneously injected E. coli RS218 at 1 × 107 CFU/ml to 
all channels. As depicted in Figure 4A, RS218 bound with the 
highest level to Spα, followed by N-SSc5D. As expected, sCD5 
displayed the lowest level of RS218 binding; however, binding of 
the bacteria to immobilized sCD6 was, although relatively low, 
noticeably higher than that binding to sCD5. This indicates that 
despite the apparent negative result of Figure  1, there is some 
above-background level of binding of sCD6 to E. coli RS218 
measurable by this SPR-based method.
Finally, we evaluated the sensitivity of the method by analyzing 
the interaction of E. coli RS218 with N-SSc5D using suspensions 
with decreasing bacteria concentration. Figure  4B represents 
again the profiles of binding of E. coli RS218 at 1 × 107 CFU/ml 
to immobilized N-SSc5D and sCD5. Then, the specific binding 
was obtained by subtracting the signals arising from the measur-
ing channels with immobilized N-SSc5D from those measured 
in the sCD5-immobilized reference channels. Three different 
concentrations of bacteria were used, 3, 5, and 10 × 106 CFU/ml, 
and for each concentration, the subtractive plots are represented 
in Figure 4C, indicating that the method clearly detects specific 
binding of E. coli RS218 to N-SSc5D even when using bacteria 
concentrations as low as 3 × 106 CFU/ml.
DiscUssiOn
The SRCR-B family comprises a group of proteins that have a 
very high level of genetic conservation and remarkable struc-
tural similarity of the SRCR domains. However, each member 
has been described with very exclusive functions, as diverse 
as roles in signal transduction, regulation of inflammation, 
cell survival and apoptosis, differentiation, detoxification in 
iron metabolism, to name just a few, to such an extent that the 
structural properties of the SRCR modules may be so far the 
only proven unifying feature of the family. This diversity in 
functions can be in part explained from the fact that each pro-
tein has unique features (different number of SRCR domains), 
is expressed in different contexts and architectures (membrane 
bound in different cell types, carrying cytoplasmic domains of 
variable lengths and compositions, or is secreted), may have 
additional domains of other types, and can display different 
degrees of posttranslational modifications, such as O- and/or 
N-glycosylation.
Recently, the description of a physical interaction between Spα, 
which is a small soluble protein almost exclusively composed of 
the three SRCR domains, and several strains of bacteria (9) pro-
jected an explicit PRR function for such type of domain. Similar 
microbe-binding properties of other SRCR proteins have indeed 
been assigned to their own SRCR domains (6–8). To further 
explore this possible unifying role for SRCR domains, we thus 
FigUre 4 | Temporal sensor response to the binding of srcr 
proteins to E. coli rs218. (a) Recombinant Spα, N-SSc5D, sCD6, and 
sCD5 were immobilized in the four sensing channels and simultaneously 
injected with an E. coli RS218 suspension of 1 × 107 CFU/ml. 
(B) Recombinant N-SSc5D and sCD5 were immobilized on alternate 
chambers, and E. coli RS218 was flowed at 1 × 107 CFU/ml. (c) The specific 
binding of E. coli RS218 to N-SSc5D was obtained by the subtraction of the 
non-specific response registered for sCD5 from the measured signals of 
E. coli RS218 binding to N-SSc5D, for bacterial concentrations of 3, 5, and 
10 × 106 CFU/ml.
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investigated the PRR-type properties of the recently described 
protein SSc5D, and more specifically of its SRCR-containing moi-
ety. For this purpose, we designed an SPR-based assay for rapid 
and direct detection of immune receptor–bacteria interactions.
Conventional methods used previously to assay the interac-
tion of bacteria with secreted recombinant SRCR (or other) 
proteins, such as flow cytometry or immunoblotting, rely on the 
labeling of proteins with a fluorescent dye, such as FITC (24), or 
with biotin targeting the sulfhydryl groups of cysteine residues (6, 
9, 10). Among the many practical advantages of the SPR method 
compared with conventional ones, there is no requirement for 
receptor labeling, and only minute amounts of protein are needed 
to generate distinct or differential signals. In our conventional 
assays shown in Figure 1, we used 5 μg of recombinant protein 
and 1 ×  108  CFU per individual receptor–bacteria assay, and 
some of these interactions were on the borderline of western blot 
sensitivity. By comparison, 2 μg of recombinant protein could be 
used in a single SPR assay testing the interaction with up to four 
bacteria types, these also used at smaller amounts (typically at 
1 × 107 CFU/ml, but feasibly down to 3 × 106 CFU/ml), which 
represent an improvement of the detection of protein–bacteria 
interactions. Moreover, the versatility of our setup allows having 
up to four different immobilized proteins and simultaneously 
comparing the binding of each protein to the same bacterial 
suspension as analyte, or conversely, comparing directly in the 
same assay suspensions of four different bacteria binding to the 
same immobilized protein.
Surface plasmon resonance biosensor technology-based affin-
ity and kinetic measurements are typically performed with analytes 
that are monovalent (25). Although through complex analyses it 
is possible to obtain such parameters in the case of multivalent 
(bacterial) contacts (26), we have utilized SPR to detect interac-
tion per se and to make synchronized measurements, obtaining 
direct comparable data for sets of four different receptors, or four 
different bacteria samples. Detection of binding of bacteria to 
macromolecules, including lipids and carbohydrates, has been 
accomplished before (26, 27), but to the best of our knowledge, 
this is the first SPR study addressing the interaction between a host 
PRR and bacteria. It should be noted that we chose to consider the 
amount of captured (irreversibly bound) bacteria to characterize 
the ability of the respective proteins to bind selected bacteria, 
as the reported experiments with bacteria are complex, and the 
binding curves in response to bacteria are not determined only 
by kinetic parameters of the interactions; they are also affected by 
other factors, such as background refractive index changes (due 
to differences in the composition of samples containing bacteria 
and running buffer), the non-specific adsorption of bacteria, or 
other non-target molecules onto the sensing surface and mass 
transport (due to rather slow diffusion of bacteria to the sensing 
surface).
From the experiments described in the present work, we show 
for the first time that, like some other human SRCR proteins, 
SSc5D, through its set of SRCR domains, has the capacity to bind 
bacteria and, from the direct comparisons established using the 
multichannel SPR apparatus, that N-SSc5D and Spα can distin-
guish between different types of bacteria on one hand and different 
strains of one type of bacteria on the other. Binding of N-SSc5D 
and Spα to E. coli RS218 gave higher sensor responses than 
binding to BL21(DE3). While BL21(DE3) is a well-characterized 
non-pathogenic research model commonly used in academic 
laboratories and in the biotech industry, RS218 is a pathogenic 
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strain belonging to the serotype O18ac:H7:K1 and displaying 
virulence factors that contribute to the onset of meningitis. The 
IHE3034 strain also belongs to the same serotype and although 
N-SSc5D binds better to IHE3034 than to BL21(DE3), the same 
behavior is not observed for Spα, suggesting that SRCR proteins 
may have very defined discriminatory properties on different, 
still undefined, extracellular components of bacteria. Likewise, 
the response signals for N-SSc5D and Spα binding to L. monocy-
togenes were significantly lower than to E. coli, possibly reflecting 
a differential sensing of Gram-positive vs. Gram-negative bacte-
ria, but at this stage and with very few bacteria types tested, it is 
premature to establish any categorization.
The interactions of N-SSc5D and Spα with E. coli RS281 were 
relatively strong and specific and, as shown for N-SSc5D, the sen-
sor responses increased proportionally to the concentration of 
the bacterial suspensions used. Comparing with the conventional 
assays, binding to E. coli IHE3034, also a meningitis-causing 
pathogen, did not give the same precise results, as N-SSc5D 
bound less and Spα bound better in the SPR experiments than in 
the bacteria-binding assays. SPR offers substantial benefits when 
compared with these methods, because it allows real-time detec-
tion of bacteria and, moreover, since bacteria are delivered under 
conditions of continuous hydrodynamic flow, the SPR technique 
is expected to better mimic the protein–bacteria interaction 
under physiological conditions where shear forces promoted 
by the body fluids are likely present (28, 29). As measurements 
are obtained simultaneously for the different proteins/bacteria 
within the same experiment, we can be confident that they truly 
reflect quantitative differences in binding of SRCR proteins to 
bacteria.
An important aspect in the design of the assay is the choice of 
a reference, which allows for the compensation of the binding of 
non-target molecules to the sensing surface. In the context of our 
study, sCD5 was defined as such based on the literature and on 
the result obtained with our conventional assay. Additionally, we 
chose to use sCD5 in experiments, as this protein is genetically 
and structurally related with the query molecules N-SSc5D and 
Spα, and thus it would account for intrinsic unspecific binding 
features that can be particular to the SRCR family of molecules.
CD6, on the other hand, was reported to bind to Gram-positive 
and Gram-negative bacterial strains (6). CD6 is a receptor of 
T lymphocytes that has characterized roles in the regulation of 
T  cell signaling and in inflammatory responses (20, 30), so its 
role as a pathogen sensor was unexpected. From the results of our 
conventional assay shown in Figure 1, we would have concluded 
that either sCD6 does not bind to the tested bacteria or that it 
binds with such low affinity that the interaction does not survive 
the pelleting and washing of the bacteria. The lack of binding 
could not be attributed to any functional defect of our produced 
sCD6 protein, as this was shown to clearly bind its natural ligand 
CD166 by flow cytometry (Figure S2 in Supplementary Material). 
However, our improved SPR assays may highlight a slightly dif-
ferent conclusion: although the level of binding of sCD6 to E. coli 
RS218 (Figure 4) or to L. monocytogenes (data not shown) was 
significantly lower than that of either N-SSc5D or Spα, it stayed 
clearly above the level of the sCD5 negative profile. Apart from 
the higher sensitivity over the previous methods, SPR is run at 
the more adequate temperature of 25°C, whereas conventional 
protein–bacteria binding assays are customarily performed at 
4°C. Notwithstanding the fact that the bacteria-binding capaci-
ties of sCD6 are reduced comparing with N-SSc5D or Spα, it is 
nonetheless very plausible that sCD6 may have true microbe-
sensing properties, which are highlighted by its capacity to 
protect animals from LPS-induced septic shock (6).
In conclusion, we have demonstrated through the use of a 
dynamic, antibody-free, SPR-based assay that N-SSc5D, like Spα, 
is capable to physically interact with whole bacteria cells. This new 
approach can be adapted to screen for interactions with a wide 
range of bacteria and once the best bacterial targets of N-SSc5D 
are identified, this will hopefully allow to better characterize and 
more deeply explore the role of this SRCR protein in pathogen 
sensing and in driving immune responses. The results obtained 
in this study using the SRCR-containing moiety of SSc5D will 
undoubtedly further our understanding of the specific function 
of SRCR domains as the functional parts of a family of mam-
malian proteins that have enhanced capabilities to recognize and 
eventually fight bacterial pathogens.
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FigUre s1 | Proteins purified and used in sPr assays. (a) Coomassie-
staining of sCD5, sCD6, and Spα proteins purified from TCS with Ni-NTA resin 
and imidazole elution. Gels of sCD6 and sCD5 (12%) and Spα (10%) were run 
under reducing conditions. Identity of the proteins was confirmed by 
immunoblotting (not shown). (B) Anionic chromatography of N-SSc5D recovered 
from TCS samples and further purification. (c) N-SSc5D fractions 43–46 were 
collected and run on 7.5% SDS-PAGE and stained with Coomassie. N-SSc5D 
expression was confirmed by immunoblotting (bottom).
FigUre s2 | scD6 binds to cells expressing its ligand, cD166. Panel of 
cells screened using recombinant sCD6 tetramers for binding to CD166. Cells 
were incubated with streptavidin-PE as an isotype control (red), sCD6 tetramers 
(blue), and sCD58 tetramers (green). (a) Jurkat and K562 cells do not express 
CD166, and therefore sCD6 tetramers showed no binding. sCD58 tetramers 
bind to CD2, which is highly expressed at the surface of the Jurkat T cell line. 
(B) The THP-1 (monocytic) and Raji (B cell) lines express CD166 at their surface 
(but not CD2) and therefore displayed binding of the sCD6 tetramers.
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